Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Immune Protocol

NisinComplete Dosing & Administration Guide

FDA GRAS-approved lantibiotic (34 amino acids) produced by Lactococcus lactis with a dual antimicrobial mechanism — binds lipid II to block cell wall synthesis AND forms 2 nm transmembrane pores for rapid bacterial killing at MIC 0.5-4 μg/mL against gram-positive pathogens including MRSA and Listeria monocytogenes — the only antimicrobial peptide with over 50 years of documented safe human consumption

Dose Range

2.5-25mg/kg (food preservation; ADI 0.13 mg/kg BW)

Frequency

Once daily

Route

Oral (food-grade preservative, GRAS)

Cycle Length

Ongoing/indefinite

Dosing

How much
do I take?

Starting Dose

2.5-5 mg/kg (food preservation standard)

Frequency

Single application during food processing

Duration

Provides antimicrobial protection throughout product shelf life

Standard food preservation concentration used in commercial dairy products, canned foods, and processed meats. At these levels, nisin is highly effective against Listeria monocytogenes and Clostridium species. This is the well-established, FDA GRAS application with decades of safety data. Optimal activity at pH 2-6.

Standard Dose

10-50 μg/mL (research topical application)

Frequency

Once or twice daily in research settings

Duration

Research protocol-dependent (typically 1-4 weeks)

Research concentration for topical antimicrobial applications including wound care models, dental applications, and antimicrobial coating development. Effective against gram-positive skin and wound pathogens including MRSA at these concentrations. Can be combined with EDTA or polymyxin to extend gram-negative coverage.

Advanced Dose

50-200 μg/mL (research applications)

Frequency

Protocol-dependent

Duration

Research protocol-dependent

Higher research concentrations for anti-biofilm studies, anticancer research, and synergy studies with gram-negative-targeting agents. At 200 μg/mL combined with EDTA, nisin provides gram-negative coverage. Anticancer IC50 against MCF-7 is approximately 12 μg/mL. Medical supervision required for any non-food applications.

Timing

Best time to take

Take Nisin at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.

With food?

Nisin can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.

If stacking

Nisin should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

  • +You've tolerated the current dose for the recommended period without significant side effects
  • +Therapeutic goals haven't been met at the current dose level
  • +Your healthcare provider recommends dose escalation based on your response
  • +Lab work or clinical assessments support a higher dose

Decrease if

  • -Side effects are bothersome or impacting daily life despite management strategies
  • -You experience any signs of an adverse reaction
  • -Lab results indicate the need for dose reduction
  • -Your healthcare provider recommends a lower dose based on your response

Signs of right dose

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Dosing Calculator

Calculate Your Exact Dose

1
2
3
4

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The weight is on the label

Peptide vial
5mg

Select Weight

mg

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do I
use it?

Reconstitution

What you need

  • Nisin in its prescribed form
  • Clean, dry storage container
  • Measuring device if applicable (oral syringe, measuring cup)
  • Calendar or reminder app for dosing schedule

Example

Nisin comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.

Use Nisin exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.

Injection

Route

Nisin is administered Oral (food-grade preservative, GRAS)—no injection required

Best sites

  • Not applicable—this is not an injectable formulation

Technique

  • 1.Follow the specific administration instructions for your Nisin formulation
  • 2.Take or apply as directed by your healthcare provider
  • 3.Store properly between uses according to package instructions

Storage

Before reconstitution

Store Nisin in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Nisin should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (once daily)

As prescribed by your healthcare provider injection

Site: Oral (food-grade preservative, GRAS)—rotate sites if applicable

Maintain a consistent schedule for optimal results with Nisin. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is it
safe?

Safety Profile

Nisin holds FDA GRAS status since 1988 with over 50 years of documented safe human consumption, making it the only antimicrobial peptide with this comprehensive long-term safety record. Oral LD50 of 174 mg/kg in mice (comparable to table salt) demonstrates extraordinary safety margin. Acceptable daily intake established at 0.13 mg/kg body weight with no reported serious adverse events at this or higher levels. Primary risk is milk protein contamination during production, requiring screening for lactose-intolerant or milk-allergic individuals.

FDA GRAS designation based on 50+ years of food-industry safety data with millions of exposed consumers globally. Bacterial production method prevents synthetic impurities; stability through pasteurization and food processing verified via microbiological and mass spectrometry analysis. Animal toxicity studies and human safety monitoring across multiple continents show no systemic toxicity, genotoxicity, or carcinogenic potential. European Food Safety Authority also designated as safe food additive (E234).

Common Side Effects

Experienced by some users

No significant effects at dietary levels

At FDA GRAS concentrations used in food preservation (ADI 0.13 mg/kg BW), nisin has no documented side effects across 50+ years of global dietary consumption by millions of people.

Management: No management needed. Nisin at dietary levels is one of the most well-documented safe food additives in history.

Mild GI discomfort at research doses

At oral doses significantly exceeding normal dietary exposure in research settings, mild gastrointestinal discomfort (nausea, mild cramping) may occur.

Management: Take with food. Reduce dose if symptoms persist. GI effects are typically transient and dose-dependent.

Local irritation (topical use)

Mild local irritation, redness, or warmth at topical application sites in wound care or dental research settings.

Management: Generally self-limiting. Reduce concentration if irritation is excessive. Nisin is most stable and active at acidic pH, which may contribute to local irritation.

Less Common

  • Milk protein allergic reaction
  • Gram-negative overgrowth

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

  • ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • ×Your healthcare provider recommends discontinuation based on your clinical response
  • ×Development of any new medical condition that may be contraindicated with Nisin
  • ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • ×Abnormal lab results or clinical markers that suggest adverse effects

Nisin should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Interactions

With other peptides

  • May be used together under medical guidance.
  • May be used together under medical guidance.
  • May be used together under medical guidance.

With medications

  • !Alkaline formulations (pH >7) — nisin activity and stability decrease significantly above neutral pH, with degradation accelerating at alkaline conditions - Use with caution—discuss with your healthcare provider.
  • !Proteolytic enzymes (trypsin, chymotrypsin at high concentrations) — while lanthionine bridges provide some resistance, extensive proteolysis can reduce activity - Use with caution—discuss with your healthcare provider.
  • !High-fat food matrices without emulsification — nisin may partition into fat phase, reducing aqueous concentration and antimicrobial activity - Use with caution—discuss with your healthcare provider.

With supplements

  • Multivitamins - Generally safe to take alongside Nisin. Space doses apart if taking oral formulations to ensure optimal absorption.
  • Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Want the Full Picture?

View the complete Nisin research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.

View Full Nisin Profile

Medical Disclaimer

Nisin is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: 2/8/2026